Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Uncover effective wealth building strategies in tough economic times to ensure your financial success. Start planning today!
19,592 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Social Security remains a cornerstone of retirement income, but 2026 brings changes that could affect when and how yo...
In a choppy 2026 market, a momentum-focused ETF is gaining attention for its track record of catching leaders while a...
A massive AI-driven data center build-out is changing how investors think about tech stocks. This piece explains the ...
Facing a potential funding gap for Social Security, seniors can take concrete steps today. Learn three actionable mea...
If you own a short-term rental, smart tax planning can save thousands. This guide shows practical steps to maximize d...
A cluster of YieldMax single-stock option income ETFs are delivering distributions that exceed their current share pr...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
A once-prolific $1,000 strategy beat the market story has turned into a cautionary tale. New investors face sharp los...
A fresh SummerFi attack on its automated Lazy Summer vaults raises questions about AI-driven risk in DeFi as guardian...
REX Shares unveils a broadened ETF lineup centered on income, leverage, crypto, and thematic strategies, aiming to me...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...